imiquimod has been researched along with Genetic Predisposition in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, D; Lohcharoenkal, W; Meisgen, F; Nikamo, P; Pivarcsi, A; Sonkoly, E; Srivastava, A; Ståhle, M; Xu Landén, N | 1 |
| Mrowietz, U; Seifert, O | 1 |
| Asselbergh, B; De Rycke, R; Declercq, W; Deforce, D; Denecker, G; Gilbert, B; Hachem, JP; Hoste, E; Prens, EP; van der Fits, L; Van Nieuwerburgh, F; Vandenabeele, P | 1 |
1 review(s) available for imiquimod and Genetic Predisposition
| Article | Year |
|---|---|
Keloid scarring: bench and bedside.
Topics: Adult; Aminoquinolines; Cicatrix; Female; Genetic Predisposition to Disease; Humans; Imiquimod; Immunity, Cellular; Interleukin-10; Keloid; Polymorphism, Genetic; Pregnancy; Quality of Life; Signal Transduction; Smad Proteins; Transforming Growth Factor beta | 2009 |
2 other study(ies) available for imiquimod and Genetic Predisposition
| Article | Year |
|---|---|
MicroRNA-146a suppresses IL-17-mediated skin inflammation and is genetically associated with psoriasis.
Topics: Adult; Aminoquinolines; Animals; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Female; Genetic Association Studies; Genetic Predisposition to Disease; Humans; Imiquimod; Interleukin-17; Keratinocytes; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; MicroRNAs; Neutrophil Infiltration; Polymorphism, Single Nucleotide; Psoriasis; Skin; Sweden | 2017 |
Caspase-14-deficient mice are more prone to the development of parakeratosis.
Topics: Aminoquinolines; Animals; Caspases; Cell Differentiation; Cell Proliferation; Disease Models, Animal; Genetic Predisposition to Disease; Imiquimod; Keratinocytes; Mice; Mice, Knockout; Parakeratosis; Psoriasis | 2013 |